Hot Features
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific ... The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The Greater Cannabis Company, Inc. was founded in 2014 and is based in Baltimore, Maryland. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.005094 | 3.18375 | 0.16 | 0.2995 | 0.145 | 6666 | 0.14807776 | CS |
| 4 | -0.035006 | -17.4942528736 | 0.2001 | 0.2995 | 0.145 | 6092 | 0.16278324 | CS |
| 12 | -0.061906 | -27.2713656388 | 0.227 | 0.4 | 0.145 | 5364 | 0.17449164 | CS |
| 26 | 0.104094 | 170.645901639 | 0.061 | 0.42 | 0.061 | 6742 | 0.20112225 | CS |
| 52 | 0.164894 | 82447 | 0.0002 | 0.42 | 0.0001 | 2188981 | 0.00048741 | CS |
| 156 | 0.164364 | 22515.6164384 | 0.00073 | 0.42 | 0.0001 | 5863037 | 0.00080499 | CS |
| 260 | 0.157294 | 2016.58974359 | 0.0078 | 0.42 | 0.0001 | 5045987 | 0.00116094 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.